May 20, 2015
When an expecting mother chooses umbilical cord blood banking during her pregnancy stages, the stem cells collected can treat a variety of diseases, including cancer and anemia treatment. One of the latest studies shows that cord blood cells can restore ovaries that have been damaged due to chemotherapy treatment, which decreases the level of sexual hormones and potentia generandi in patients. This ovarian restoration will greatly improve quality of life for patients, which is another reason to consider umbilical cord blood banking during your stages of pregnancy.
A study utilizing lab rats showed that damaged ovaries could be treated using umbilical cord stem cells injected in a minimally invasive manner through the tail, maintaining quality of life for patients that may have previously used cord blood for anemia treatment during their pregnancy stages. The case rats were observed to have their levels of sex hormones, potentia generandi, and estrous cycle restored to some degree. In some of the rats that were treated, fertility was restored and their offspring developed normally. These rats could have recorded these functions faster had the stem cells been injected directly in their ovaries, but both methods produced similar results, giving a nod to the more minimally invasive method.
Few studies have been published that describe the use of mesenchymal stem cells from cord blood to treat chemotherapy-induced premature ovarian failure, but stem cell research is continually growing and expanding, meaning cord blood could be found useful to treat a disease tomorrow that it isn’t known to treat today. As clinical trials continue to expand, scientists will study the use of cord blood to restore damaged ovaries in human patients. Because cord blood can only be collected at the birth of a child and is constantly increasing in usability, it is fair to say that cord blood banking is something all expecting mothers should consider during their stages of pregnancy.
May 18, 2015
Cord blood stem cells are currently used to treat more than 80 diseases, with ongoing stem cell research and clinical trials continually finding new treatments and cures. Currently, cord blood is used to treat various types of cancers, leukemias, anemia treatment, and more. For those who are unfamiliar with umbilical cord blood banking and may ask, “What is stem cell research?”, you have come to the right place.
Umbilical cord blood banking is a special process that collects and stores blood from the umbilical cord of a newborn child, as this cord blood is rich in mesenchymal stem cells, which can be used to treat a variety of diseases. The process of cord blood banking is safe and painless for both mother and child, and saves cord blood for future use, as it would otherwise be discarded as medical waste. Because cord blood can only be collected at the birth of a child, it is important for expecting mothers to consider it during their stages of pregnancy.
Umbilical cord matrix mesenchymal stem cells found in both humans and rats possess the ability to control the growth of breast carcinoma cells. Comparative analysis of these two types of stem cells suggest that the cells found in rats are significantly stronger than the cells found in humans when it comes to suppressing the growth of breast cancer. However, one study found that there is a possibility for the human cells to be transformed into much stronger tumoricidal cells by enhancing tumor suppressor gene expression. This means that umbilical cord blood could be a viable option to suppress the growth of breast cancer, allowing for treatment. This was the first study to evaluate and describe the potential use of human cord blood stem cells to create an endogenous tumor suppressor gene for breast cancer treatment.
This is the first study to describe potential use of human UCMSC engineered to express an endogenous tumor suppressor gene for breast cancer treatment. This study clearly indicates that engineering human UCMSC by endogenous tumor suppressor genes can re-enforce UCMSC-dependent tumoricidal ability. It is apparent that generation of more effective human UCMSC requires further studies for efficient cell preparation and long-lasting gene transduction methods.
May 15, 2015
Many diseases that cord blood banking can treat are hereditary, meaning if someone in your family had a particular disease, there is a greater chance that your children could develop it as well. Fortunately, cord blood banking allows you to prepare for this possibility during your stages of pregnancy, before your children are even born. More and more parents are discovering the capability of the stem cells found in the umbilical cord blood and tissue of their newborns, which can be collected and stored in CariCord’s private umbilical cord blood banking center.
Currently, cord blood is known to treat more than 80 diseases, including several cancers and anemia treatment, with research underway for more potential therapies and treatments. What is stem cell research? Well, a portion of it involves discovering new uses for umbilical cord blood, which expecting mothers can decide to bank during their pregnancy stages. As stem cell research continues to advance, it is likely that cord blood will be able to treat even more diseases in the near future.
Most of the time cord blood that is collected and stored through a cord blood banking service after a mother’s stages of pregnancy, is used to treat a future disease in that same child, although it can also be used to treat another child that is a match. Generally, 25-30% of siblings are matches, so the decision made during your pregnancy stages to bank your child’s cord blood could in fact affect your other children who have already been born, should they ever develop a disease that cord blood can be used to treat. This makes umbilical cord blood banking especially beneficial if there is a history of disease in your family.
More than 1,500 children are diagnosed with lymphoma annually. Reports show it is the third most common cancer in children, and was expected to take the lives of more than 20,000 people in 2014 alone. This is a disease that cord blood can treat, which is why stem cell research and umbilical cord blood banking is something every expecting mother should look into during her stages of pregnancy.
May 13, 2015
When an expecting mother makes the decision to store her child’s cord blood during her stages of pregnancy, she is making an investment in the future of her child. Currently, cord blood is known to effectively treat more than 80 diseases, and FDA-regulated clinical studies are currently underway to research treatment for many more diseases, including: autism, cerebral palsy, pediatric stroke, acquired hearing loss, or traumatic brain injuries. These conditions currently have no cure through regenerative medicine. What is stem cell research? It is finding cures for these conditions through umbilical cord blood banking.
A 2010 study found that stem cells found in umbilical cord blood improved the neurologic function of lab rats after an acute spinal cord injury. The rats in the study improved recovery of their motor function in 6 weeks, compared to rats that did not receive the stem cell treatment. Continued stem cell research will hopefully make treatment of spinal cord injuries through cord blood possible in human patients.
Cord blood can currently be used for anemia treatment, and may be able to treat lung disease in the future, which is why expecting mothers should decide to store their child’s cord blood during their stages of pregnancy. Stem cell research has shown that mesenchymal cells, which are found in umbilical cord blood, can possibly significantly reduce lung inflammation in infants who suffer from bronchopulmonary dysplasia, a lung disease that effects premature infants who receive oxygen supplementation and ventilator support to treat respiratory conditions. This can possibly save the lives of many children, which is why umbilical cord blood research is an area to pay attention to and why expecting mothers should consider saving their child’s cord blood during their stages of pregnancy.
While umbilical cord blood banking can also play a key role in treating certain types of cancers and anemia treatment, stem cell research is currently underway to investigate the possibility of using cord blood stem cells to treat stroke, Parkinson’s disease, Alzheimer’s disease, peripheral artery occlusive disease, rheumatoid arthritis, and liver disease. In the future, cord blood could also possibly be used in bone repair, heart repair, and wound healing in diabetics caused by nerve damage, poor circulation, or complications within a patient’s immune system.